In 2022, Christy Scattarella felt like her brain was unraveling. The Portlander, then 63, kept misplacing items such as her ...
Blood-based biomarker test had similar false-positive rate as PSA, while reducing false ne ...
The global PD-L1 Biomarker Testing Market is witnessing robust expansion as precision oncology, immunotherapy adoption, and ...
The discussion transitions to biomarker testing as an essential component of lung cancer diagnosis, with Dr. Florez ...
Precision Care Companion (PCC) enhances biomarker testing and precision therapy adoption in community oncology, uniting practices, labs, and biopharma for improved patient outcomes. PCC focuses on ...
Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — More than one-third of U.S. adults diagnosed with metastatic HER2-negative breast cancer in 2023 ...
Cizzle Bio, Inc., a Texas-based biotechnology company advancing biomarker blood tests for early detection of lung and gastric cancers, today announced the laboratory validation of its proprietary ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces challenges in uptake and education. Multistakeholder partnerships and ...
Dr. John Marshall explains why biomarker testing should be done early in colorectal cancer to guide treatment and identify targeted therapies. Biomarker testing is no longer optional in colorectal ...
Biomarkers are measurable indicators that can be tested to reveal important details about a cancer. Information about these biomarkers can help guide the best treatment for you, predict your response ...
RALEIGH, N.C. (WTVD) -- Cancer advocates, patients and doctors gathered at the North Carolina Legislature on Tuesday to support legislation aimed at expanding access to biomarker testing for cancer ...
Two years ago, on World Cancer Day (Feb. 4), the GI Cancers Alliance launched an online education initiative to increase awareness about early biomarker testing in U.S. patients with gastric cancer.